Lanperisone

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 598375

CAS#: 116287-14-0

Description: Lanperisone is a muscle relaxant.


Price and Availability

Size
Price

Size
Price

Size
Price

Lanperisone is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 598375
Name: Lanperisone
CAS#: 116287-14-0
Chemical Formula: C15H18F3NO
Exact Mass: 285.134
Molecular Weight: 285.31
Elemental Analysis: C, 63.15; H, 6.36; F, 19.98; N, 4.91; O, 5.61


Synonym: Lanperisone;

IUPAC/Chemical Name: (R)-2-methyl-3-(pyrrolidin-1-yl)-1-(4-(trifluoromethyl)phenyl)propan-1-one

InChi Key: RYZCWZZJFAKYHX-LLVKDONJSA-N

InChi Code: InChI=1S/C15H18F3NO/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18/h4-7,11H,2-3,8-10H2,1H3/t11-/m1/s1

SMILES Code: O=C(C1=CC=C(C(F)(F)F)C=C1)[C@H](C)CN2CCCC2


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.03.00


References

1: Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, Lewis TA, Maglathin RL, Tolliday N, Jacks T. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci U S A. 2011 May 24;108(21):8773-8. doi: 10.1073/pnas.1105941108. Epub 2011 May 9. PubMed PMID: 21555567; PubMed Central PMCID: PMC3102385.

2: Sakitama K, Ozawa Y, Aoto N, Tomita H, Ishikawa M. Effects of a new centrally acting muscle relaxant, NK433 (lanperisone hydrochloride) on spinal reflexes. Eur J Pharmacol. 1997 Oct 22;337(2-3):175-87. PubMed PMID: 9430412.

3: Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014 Nov 1;92(1):90-101. doi: 10.1016/j.bcp.2014.07.017. Epub 2014 Jul 28. Review. PubMed PMID: 25078786.

4: Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I. Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. Epub 2005 Aug 26. PubMed PMID: 16126840.